Corventis, a maker of wireless CHF monitoring devices that measure heart rate, heart rate variability, respiratory rate, fluid status and activity, and West Wireless Health Institute, a research organization promoting wireless technology use in medicine, have teamed up to conduct multi center clinical trials of the Piix device, a monitoring gadget we have profiled before.
From the press release:
Corventis’ remote monitoring wireless system was approved by the FDA in February 2009, which sets up the potential for a multicenter, randomized clinical trial. The trial will be spearheaded by the West Wireless Health Institute and led by Dr. Eric J. Topol, the Institute’s chief medical officer. Dr. Topol is also chief academic officer at Scripps Health and holder of the Gary and Mary West Chair of Innovative Medicine.
Participation in the pivotal randomized trial with WWHI and Corventis will be offered to the sites supported by the National Institutes of Health Clinical and Translational Science Award (CTSA) National Consortium, which consists of 38 of the most prestigious academic medical centers in the United States. The trial is designed to clinically validate remote wireless monitoring technology in proactively managing heart failure patients and reducing hospital readmissions.
Press release: West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial…
Links: West Wireless Health Institute; Corventis technology…
Flashback: PiiX Monitors for Signs of Decompensated Heart Failure…